124 related articles for article (PubMed ID: 14619474)
21. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
[TBL] [Abstract][Full Text] [Related]
22. [Experimental study on CPT-11 intraperitoneal chemotherapy--metabolism of CPT-11 in malignant ascites].
Maruyama M; Toukairin Y; Baba H; Yoshida T; Kure N; Nagahama T; Ebuchi M
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1858-60. PubMed ID: 11086430
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.
Verschraegen CF; Kudelka AP; Hu W; Vincent M; Kavanagh JJ; Loyer E; Bastien L; Duggal A; De Jager R
Cancer Chemother Pharmacol; 2004 Jan; 53(1):1-7. PubMed ID: 14586557
[TBL] [Abstract][Full Text] [Related]
24. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
25. Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer.
Yonemura Y; Endou Y; Bando E; Kuno K; Kawamura T; Kimura M; Shimada T; Miyamoto K; Sasaki T; Sugarbaker PH
Cancer Lett; 2004 Jul; 210(2):189-96. PubMed ID: 15183534
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH
Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of intravenous and intraperitoneal paclitaxel with S-1 in pancreatic ductal adenocarcinoma patients with peritoneal metastasis: a retrospective study in a single institution.
Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Hashimoto Y; Matsui Y; Kon M
J Hepatobiliary Pancreat Sci; 2017 May; 24(5):289-296. PubMed ID: 28301088
[TBL] [Abstract][Full Text] [Related]
28. Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse.
Azuma H; Tomita N; Sakamoto T; Kiyama S; Inamoto T; Takahara K; Kotake Y; Segawa N; Morishita R; Takahara S; Hayasaki H; Otsuki Y; Horie S; Tanigawa N; Katsuoka Y
Int J Cancer; 2008 Apr; 122(7):1645-56. PubMed ID: 18058816
[TBL] [Abstract][Full Text] [Related]
29. [A patient with peritoneal metastasis from gastric cancer who responded to weekly chemotherapy with paclitaxel on the third line and could take meal].
Nakae S; Urakawa T; Yamamoto M; Kinoshita H; Sainoh K; Kitaura T; Takahashi T; Takao S; Shiroiwa H; Onoyama H; Sugihara S; Toyota J; Saitoh Y
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1161-4. PubMed ID: 12938274
[TBL] [Abstract][Full Text] [Related]
30. Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Maki H; Hojo K; Tanaka H; Sawada TY; Maekawa R; Yoshioka T
Clin Exp Metastasis; 2002; 19(6):519-26. PubMed ID: 12405289
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of recurrent gastric cancer].
Tsushima K; Sakata Y
Gan To Kagaku Ryoho; 1998 Feb; 25(3):321-6. PubMed ID: 9492823
[TBL] [Abstract][Full Text] [Related]
32. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.
Muñoz-Casares FC; Rufián S; Arjona-Sánchez Á; Rubio MJ; Díaz R; Casado Á; Naranjo Á; Díaz-Iglesias CJ; Ortega R; Muñoz-Villanueva MC; Muntané J; Aranda E
Cancer Chemother Pharmacol; 2011 Jul; 68(1):267-74. PubMed ID: 21499894
[TBL] [Abstract][Full Text] [Related]
34. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H
Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258
[TBL] [Abstract][Full Text] [Related]
35. RGD-containing peptides inhibit experimental peritoneal seeding of human ovarian cancer cells.
Yamamoto K; Murae M; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1687-92. PubMed ID: 1744466
[TBL] [Abstract][Full Text] [Related]
36. Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.
Otto J; Jansen PL; Lucas S; Schumpelick V; Jansen M
BMC Cancer; 2007 Jun; 7():104. PubMed ID: 17584925
[TBL] [Abstract][Full Text] [Related]
37. PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse.
Konishi H; Takagi A; Kurita A; Kaneda N; Matsuzaki T
BMC Cancer; 2012 Oct; 12():462. PubMed ID: 23046546
[TBL] [Abstract][Full Text] [Related]
38. [Safety of intraperitoneal chemotherapy with paclitaxel in gastric cancer patients with peritoneal dissemination].
Fujitani K; Hirao M; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1855-7. PubMed ID: 15553738
[TBL] [Abstract][Full Text] [Related]
39. [Cisplatin/5-fluorouracil intraperitoneal administration superior to intravenous administration for liver metastases of colonic carcinoma].
Maruyama M; Kudo T; Kuwahara H; Takamatsu S; Sugano N; Ebuchi M
Gan To Kagaku Ryoho; 1997 Oct; 24(13):2011-4. PubMed ID: 9350251
[TBL] [Abstract][Full Text] [Related]
40. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer].
Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
